Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic

  • You have access
    Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
    Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557
  • You have access
    Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
    Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer and Peter Kletting
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 92-98; DOI: https://doi.org/10.2967/jnumed.120.245068
  • TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using <sup>225</sup>Ac-Labeled DOTAylated-huCC49 Antibody
    You have access
    TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
    Megan Minnix, Lin Li, Paul J. Yazaki, Aaron D. Miller, Junie Chea, Erasmus Poku, An Liu, Jeffrey Y.C. Wong, Russell C. Rockne, David Colcher and John E. Shively
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 55-61; DOI: https://doi.org/10.2967/jnumed.120.243394
  • Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
    You have access
    Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
    Gyu Seong Heo, Geetika Bajpai, Wenjun Li, Hannah P. Luehmann, Deborah H. Sultan, Hao Dun, Florian Leuschner, Steven L. Brody, Robert J. Gropler, Daniel Kreisel, Kory J. Lavine and Yongjian Liu
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 111-114; DOI: https://doi.org/10.2967/jnumed.120.244673
  • Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
    You have access
    Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
    Christian Sacher, Tanja Blume, Leonie Beyer, Gloria Biechele, Julia Sauerbeck, Florian Eckenweber, Maximilian Deussing, Carola Focke, Samira Parhizkar, Simon Lindner, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Karlheinz Baumann, Sabina Tahirovic, Gernot Kleinberger, Michael Willem, Christian Haass, Peter Bartenstein, Paul Cumming, Axel Rominger, Jochen Herms and Matthias Brendel
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1825-1831; DOI: https://doi.org/10.2967/jnumed.120.242750
  • Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
    You have access
    Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
    Carleen Cullinane, Charmaine M. Jeffery, Peter D. Roselt, Ellen M. van Dam, Susan Jackson, Kevin Kuan, Price Jackson, David Binns, Jessica van Zuylekom, Matthew J. Harris, Rodney J. Hicks and Paul S. Donnelly
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1800-1805; DOI: https://doi.org/10.2967/jnumed.120.243543
  • Synthesis of the PET Tracer <sup>124</sup>I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    You have access
    Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty and Jan Grimm
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1845-1850; DOI: https://doi.org/10.2967/jnumed.120.241901
  • You have access
    Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
    Thijs S. Stutvoet, Elly L. van der Veen, Arjan Kol, Inês F. Antunes, Erik F.J. de Vries, Geke A.P. Hospers, Elisabeth G.E. de Vries, Steven de Jong and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1839-1844; DOI: https://doi.org/10.2967/jnumed.119.241364
  • Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled FAP Inhibitor
    You have access
    Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
    Johannes Toms, Jürgen Kogler, Simone Maschauer, Christoph Daniel, Christian Schmidkonz, Torsten Kuwert and Olaf Prante
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1806-1813; DOI: https://doi.org/10.2967/jnumed.120.242958
  • Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
    Open Access
    Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
    Julia Baguña Torres, Michael Mosley, Sofia Koustoulidou, Samantha Hopkins, Stefan Knapp, Apirat Chaikuad, Masuo Kondoh, Keisuke Tachibana, Veerle Kersemans and Bart Cornelissen
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1756-1763; DOI: https://doi.org/10.2967/jnumed.120.243113

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 28
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire